You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 17 No. 3, September 1967 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Lipids in Blood Plasma and Erythrocytes in Juvenile Amaurotic Idiocy

Cholestyramine Therapy

S. van Creveld, MD; G. J. M. Hooghwinkel, PhD

Arch Neurol. 1967;17(3):225-229.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN THE study of disturbances in lipid metabolism—with or without cerebral symptoms—lipids of erythrocytes and plasma or serum have also been implicated recently.1-14 In generalized disorders of lipid metabolism, even when manifest by localization in certain tissues, abnormalities of plasma and erythrocytes might be of diagnostic significance or important for genetic studies.

Cholestyramine resin (Questran) is a basic anion-exchange resin with a special affinity for bile acids. After oral administration of cholestyramine resin, the bile acids are sequestered in the gut, thus preventing their reabsorption and promoting excretion in the feces. In this way the oxidation conversion of cholesterol to bile acids should be intensified, followed by a decrease of serum cholesterol (and possibly in other tissues). There are indications that the absorption of dietary cholesterol from the intestine may also be prevented by cholestyramine resin. Administration of cholestyramine resin lowers serum cholesterol in such conditions as intrahepatic . . . [Full Text PDF of this Article]


Author Affiliations

Amsterdam and Leiden, the Netherlands

From the Pediatric Clinic of the University of Amsterdam and the Department of Medical Chemistry, State-University of Leiden, the Netherlands.


Footnotes

Submitted for publication Feb 2, 1967; accepted May 2.

Reprint requests to Department of Medical Chemistry, State-University of Leiden, the Netherlands (Dr. Hooghwinkel).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1967 American Medical Association. All Rights Reserved.